Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus lidocaine versus saline for recovery and emotional outcomes after thyroidectomy
ChiCTR2100043935Phase 4Recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and lidocaine in thyroid neoplasm (3 arms), sponsored by Huai'an Second Hospital. Primary endpoints: QoR-40, SAS and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
esketaminelidocaine
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on ChiCTR2100043935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043935.